N.G.IND.LTD. | DR LALCHANDANI LABS | N.G.IND.LTD./ DR LALCHANDANI LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 9.4 | - | - | View Chart |
P/BV | x | 1.5 | 0.8 | 185.1% | View Chart |
Dividend Yield | % | 2.1 | 0.0 | - |
N.G.IND.LTD. DR LALCHANDANI LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
N.G.IND.LTD. Mar-24 |
DR LALCHANDANI LABS Mar-24 |
N.G.IND.LTD./ DR LALCHANDANI LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 230 | 35 | 657.1% | |
Low | Rs | 70 | 16 | 446.4% | |
Sales per share (Unadj.) | Rs | 50.4 | 11.1 | 453.7% | |
Earnings per share (Unadj.) | Rs | 15.0 | 1.4 | 1,052.9% | |
Cash flow per share (Unadj.) | Rs | 16.8 | 2.9 | 585.8% | |
Dividends per share (Unadj.) | Rs | 3.50 | 0 | - | |
Avg Dividend yield | % | 2.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 107.9 | 22.0 | 489.6% | |
Shares outstanding (eoy) | m | 3.35 | 4.33 | 77.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.0 | 2.3 | 130.4% | |
Avg P/E ratio | x | 10.0 | 17.8 | 56.1% | |
P/CF ratio (eoy) | x | 8.9 | 8.8 | 101.0% | |
Price / Book Value ratio | x | 1.4 | 1.2 | 120.8% | |
Dividend payout | % | 23.3 | 0 | - | |
Avg Mkt Cap | Rs m | 503 | 110 | 457.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 21 | 7 | 297.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 169 | 48 | 351.0% | |
Other income | Rs m | 45 | 3 | 1,615.1% | |
Total revenues | Rs m | 214 | 51 | 420.4% | |
Gross profit | Rs m | 20 | 13 | 149.9% | |
Depreciation | Rs m | 6 | 6 | 95.5% | |
Interest | Rs m | 1 | 4 | 19.5% | |
Profit before tax | Rs m | 59 | 6 | 947.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 8 | 0 | - | |
Profit after tax | Rs m | 50 | 6 | 814.6% | |
Gross profit margin | % | 12.0 | 28.0 | 42.7% | |
Effective tax rate | % | 14.0 | 0 | - | |
Net profit margin | % | 29.8 | 12.8 | 232.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 50 | 95 | 52.8% | |
Current liabilities | Rs m | 17 | 50 | 34.5% | |
Net working cap to sales | % | 19.4 | 92.5 | 20.9% | |
Current ratio | x | 2.9 | 1.9 | 152.9% | |
Inventory Days | Days | 633 | 115 | 549.2% | |
Debtors Days | Days | 3,137 | 3,570 | 87.9% | |
Net fixed assets | Rs m | 349 | 55 | 633.6% | |
Share capital | Rs m | 34 | 43 | 77.3% | |
"Free" reserves | Rs m | 328 | 52 | 629.6% | |
Net worth | Rs m | 361 | 95 | 378.8% | |
Long term debt | Rs m | 0 | 3 | 0.0% | |
Total assets | Rs m | 399 | 150 | 266.3% | |
Interest coverage | x | 79.1 | 2.6 | 3,032.6% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.4 | 0.3 | 131.8% | |
Return on assets | % | 12.8 | 6.7 | 191.6% | |
Return on equity | % | 13.9 | 6.5 | 215.2% | |
Return on capital | % | 16.4 | 10.2 | 160.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -10 | -2 | 467.9% | |
From Investments | Rs m | 22 | 10 | 225.5% | |
From Financial Activity | Rs m | -6 | -16 | 37.7% | |
Net Cashflow | Rs m | 6 | -8 | -77.7% |
Indian Promoters | % | 74.5 | 57.2 | 130.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 25.5 | 42.8 | 59.6% | |
Shareholders | 2,199 | 175 | 1,256.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare N.G.IND.LTD. With: APOLLO HOSPITALS NARAYANA HRUDAYALAYA DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | N.G.IND.LTD. | DR LALCHANDANI LABS |
---|---|---|
1-Day | -2.86% | -3.90% |
1-Month | 1.37% | -11.24% |
1-Year | 0.74% | -35.71% |
3-Year CAGR | 49.25% | -17.02% |
5-Year CAGR | 23.34% | -2.57% |
* Compound Annual Growth Rate
Here are more details on the N.G.IND.LTD. share price and the DR LALCHANDANI LABS share price.
Moving on to shareholding structures...
The promoters of N.G.IND.LTD. hold a 74.5% stake in the company. In case of DR LALCHANDANI LABS the stake stands at 57.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of N.G.IND.LTD. and the shareholding pattern of DR LALCHANDANI LABS.
Finally, a word on dividends...
In the most recent financial year, N.G.IND.LTD. paid a dividend of Rs 3.5 per share. This amounted to a Dividend Payout ratio of 23.3%.
DR LALCHANDANI LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of N.G.IND.LTD., and the dividend history of DR LALCHANDANI LABS.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.